Ilyas Sahin

Ilyas Sahin practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Ilyas Sahin's NPI, 1174936835, was assigned on June 10, 2014. Ilyas Sahin holds Massachusetts license 1019472.

Ilyas Sahin's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Ilyas Sahin's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Ilyas Sahin is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Hospital. Dmand AI also links Ilyas Sahin to 1 more hospital, 3 medical groups and 1 community health center, each named with a free account. Ilyas Sahin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Ilyas Sahin practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Ilyas Sahin's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Ilyas Sahin's licenses on file in 3 states: Massachusetts, Florida and Rhode Island.

CMS data shows 189 Medicare services from Ilyas Sahin across 5 procedure codes in 2024, for 95 Medicare patients. Medicare paid $18,796 for them.

CMS counts 95 Medicare patients who saw Ilyas Sahin in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ilyas Sahin's median patient age at 71, with 35% women.

In 2024, Ilyas Sahin wrote 377 Medicare Part D claims for 80 patients. 80% of them were for generic drugs. CMS names the drug for 240 of them, across 11 drugs with 11 or more claims each, at $690,905 in total drug cost. In 2023, CMS named 309 claims across 12 drugs.

Ilyas Sahin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ilyas Sahin as offering telehealth.

Dmand AI links 62 papers to Ilyas Sahin, published from 2010 to 2025. 2023 was the busiest year, with 10. The most frequent topics are Antineoplastic Agents, Breast Neoplasms and Multiple Myeloma. Ilyas Sahin has published most often in J BUON. Ilyas Sahin's most frequent co-authors are Erhan Ararat, MD, Muhammet Ozer, MD and Thomas J. George, MD.

CMS Open Payments shows 8 general payments to Ilyas Sahin from 5 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 87% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,398.